focus -WSS

focus

author：knowledge 2025-10-01 12:34:00 - browse：5612

Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT — Adobe

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： CDC backtracks, saying fully vaccinated people can go maskless indoors

WSS

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

As Taiwan prepares for anti

Why an extreme heat and wildfire smoke combination can be so dangerous

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Organ transplantation is at a crossroads. Major reform is needed

Caitlin Bernard's story shows physicians can't shy from advocacy

hotspot

focus

focus

Medicare details structure of new drug price negotiation program

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Alkermes shareholders re

Synthetic human embryos? Researchers say term is overblown

DIEP, the 'gold standard' of breast reconstruction, is under threat

What to know about Saharan dust affecting the US and how it can affect health

How one medical school became remarkably diverse

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

23andMe had bad news about my health. I wish a person had delivered it

Why do we get seasonal allergies?

focus

Illumina to lay off 10% of research and development team

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Elizabeth Warren probes abortion access

Court strikes down limits on filming of police in Arizona

In new study, freeze

FDA official pushes for dedicated emerging pathogens team

hotspot

focus

entertainment

explore